These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 32718668)
1. Differential anatomical and cellular expression of lysophosphatidic acid receptor 1 in adult mouse brain. Kajitani N; Okada-Tsuchioka M; Kano K; Omori W; Boku S; Aoki J; Takebayashi M Biochem Biophys Res Commun; 2020 Oct; 531(2):89-95. PubMed ID: 32718668 [TBL] [Abstract][Full Text] [Related]
2. Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain. González de San Román E; Manuel I; Giralt MT; Chun J; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Ferrer I; Rodríguez-Puertas R J Neurochem; 2015 Aug; 134(3):471-85. PubMed ID: 25857358 [TBL] [Abstract][Full Text] [Related]
3. LPA Suckau O; Gross I; Schrötter S; Yang F; Luo J; Wree A; Chun J; Baska D; Baumgart J; Kano K; Aoki J; Bräuer AU Dev Dyn; 2019 May; 248(5):375-395. PubMed ID: 30847983 [TBL] [Abstract][Full Text] [Related]
4. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury. Santos-Nogueira E; López-Serrano C; Hernández J; Lago N; Astudillo AM; Balsinde J; Estivill-Torrús G; de Fonseca FR; Chun J; López-Vales R J Neurosci; 2015 Jul; 35(28):10224-35. PubMed ID: 26180199 [TBL] [Abstract][Full Text] [Related]
5. Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass. Gennero I; Laurencin-Dalicieux S; Conte-Auriol F; Briand-Mésange F; Laurencin D; Rue J; Beton N; Malet N; Mus M; Tokumura A; Bourin P; Vico L; Brunel G; Oreffo RO; Chun J; Salles JP Bone; 2011 Sep; 49(3):395-403. PubMed ID: 21569876 [TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid and its receptor LPA Srikanth M; Chew WS; Hind T; Lim SM; Hay NWJ; Lee JHM; Rivera R; Chun J; Ong WY; Herr DR Eur J Pharmacol; 2018 Dec; 841():49-56. PubMed ID: 30321532 [TBL] [Abstract][Full Text] [Related]
9. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease. Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of lysophosphatidic acid receptor 1 mutants identified in rat cancer tissues. Ishii S; Tsujiuchi T; Fukushima N Biochem Biophys Res Commun; 2017 May; 486(3):767-773. PubMed ID: 28342860 [TBL] [Abstract][Full Text] [Related]
11. Application of in utero electroporation of G-protein coupled receptor (GPCR) genes, for subcellular localization of hardly identifiable GPCR in mouse cerebral cortex. Kim NH; Kim S; Hong JS; Jeon SH; Huh SO Mol Cells; 2014 Jul; 37(7):554-61. PubMed ID: 25078448 [TBL] [Abstract][Full Text] [Related]
12. Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis Pathogenesis. Fransson J; Gómez-Conde AI; Romero-Imbroda J; Fernández O; Leyva L; de Fonseca FR; Chun J; Louapre C; Van-Evercooren AB; Zujovic V; Estivill-Torrús G; García-Díaz B Mol Neurobiol; 2021 Feb; 58(2):470-482. PubMed ID: 32974731 [TBL] [Abstract][Full Text] [Related]
13. Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration. Nan L; Wei J; Jacko AM; Culley MK; Zhao J; Natarajan V; Ma H; Zhao Y Biochim Biophys Acta; 2016 Feb; 1863(2):229-35. PubMed ID: 26597701 [TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic Acid Signaling through the Lysophosphatidic Acid-1 Receptor Is Required for Alveolarization. Funke M; Knudsen L; Lagares D; Ebener S; Probst CK; Fontaine BA; Franklin A; Kellner M; Kühnel M; Matthieu S; Grothausmann R; Chun J; Roberts JD; Ochs M; Tager AM Am J Respir Cell Mol Biol; 2016 Jul; 55(1):105-16. PubMed ID: 27082727 [TBL] [Abstract][Full Text] [Related]
15. Study of lysophosphatidic acid receptors (LPARs) in buffalo uterus demonstrated upregulation of LPAR1 and LPAR6 in early pregnancy. Sadam A; Parida S; Padol AR; Verma AD; Baba NA; Khuman WM; Srivastava V; Panigrahi M; Singh TU; Sarkar SN Theriogenology; 2017 Sep; 99():90-97. PubMed ID: 28708504 [TBL] [Abstract][Full Text] [Related]
16. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts. Olianas MC; Dedoni S; Onali P Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927 [TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure. Panchatcharam M; Miriyala S; Yang F; Rojas M; End C; Vallant C; Dong A; Lynch K; Chun J; Morris AJ; Smyth SS Circ Res; 2008 Sep; 103(6):662-70. PubMed ID: 18703779 [TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells. Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008 [TBL] [Abstract][Full Text] [Related]
19. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells. Chen M; Towers LN; O'Connor KL Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233 [TBL] [Abstract][Full Text] [Related]
20. Fear extinction and acute stress reactivity reveal a role of LPA(1) receptor in regulating emotional-like behaviors. Pedraza C; Sánchez-López J; Castilla-Ortega E; Rosell-Valle C; Zambrana-Infantes E; García-Fernández M; Rodriguez de Fonseca F; Chun J; Santín LJ; Estivill-Torrús G Brain Struct Funct; 2014 Sep; 219(5):1659-72. PubMed ID: 23775489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]